Susan Hertzberg_BrainScope.JPG

Susan Hertzberg

Chief Executive Officer

Susan is an innovative and successful healthcare executive with over 30 years of diagnostics, products and services experience. She joined BrainScope in June of 2019.

Most recently, Susan was Chief Executive Officer of private equity backed Prelude Fertility, a comprehensive fertility services company.  In just two years, Susan drove the commercial strategy, built the team and created the largest and fastest growing fertility services company in the country with over 28 locations in 14 states.  She also completed a first of its kind deal with NYU Langone.  Prelude completed a merger with Conception Fertility in April of 2019.   

Prior to joining Prelude, Susan spent more than six years as President and Chief Executive Officer of Boston Heart Diagnostics, a diagnostics services start-up backed Bain Capital Ventures.  During her tenure at Boston Heart, the company grew organically from $4M to just under $95M in 5 years, went from 30 to 550 employees and tested over one million patients.  Susan led the successful exit of Boston Heart in January 2015, in a deal valued at just under $200M.  

Prior to Boston Heart, Susan was Chief Executive Officer at Ipsogen Inc, a molecular diagnostics company with products focused on blood and breast cancers. In less than 3 years, she built the US into the largest market within Ipsogen and along with the Founder CEO co-led the M&A that resulted in the sale of the company to Qiagen.  Susan spent the earlier part of her career at Quest Diagnostics where she held various executive positions including head of marketing, corporate identity, payer contracting, and supply chain and materials management. She also spent time at Abbott Diagnostics and Oxford Health Plans (now part of United Healthcare).  

Susan’s deep experience in a variety of diagnostics, provider services and payer contracting companies have given her a unique perspective on the market. She has successfully anticipated shifting healthcare trends throughout her career and has used this to innovate and drive growth under a variety of conditions. 

Susan received a MBA from Columbia University and is an EY “Entrepreneur of the Year.” (2014).  She serves on the board of directors of BreastCancer.Org and is a strategic advisor to the Founders Affiliate Board of Directors of the American Heart Association.